文献速递神经肿瘤

2-羟基戊二酸磁共振波谱预测异柠檬酸脱氢酶突变型胶质瘤:基于个体患者数据的系统综述与Meta分析

2-Hydroxyglutarate MR spectroscopy for prediction of isocitrate dehydrogenase mutant glioma: a systemic review and meta-analysis using individual patient data.
PubMed 文献 · Neuro Oncol · 2018-01-01

该系统综述与Meta分析检索截至2018年3月20日的文献,纳入14篇原始文章共460例患者,评估2-羟基戊二酸(2HG)磁共振波谱(MRS)预测IDH突变型胶质瘤的诊断性能。合并敏感度为95%(95%CI 85-98%),合并特异度为91%(95%CI 83-96%);基于个体患者数据得出的2HG最佳截断值为1.76 mM。

要点

  • 2HG MRS预测IDH突变型胶质瘤的合并敏感度为95%(95%CI 85-98%),合并特异度为91%(95%CI 83-96%)。
  • 敏感度存在异质性(I²=50.69%),特异度未见异质性(I²=30.37%);Meta回归显示回波时间与研究异质性相关。
  • PRESS序列中长TE(97 ms)的敏感度92%、特异度97%,高于短TE(30-35 ms)的敏感度90%、特异度88%(P<0.01);个体患者数据得出的2HG最佳截断值为1.76 mM。

核心结论

  • 2HG MRS对预测IDH突变型胶质瘤表现出极好的特异度,回波时间与敏感度的异质性相关。

研究设计与样本

  • 系统综述与Meta分析,检索Ovid-MEDLINE和EMBASE截至2018年3月20日的原始文章,纳入14篇原始文章共460例患者。

主要发现

  • 2HG MRS预测IDH突变型胶质瘤的合并敏感度为95%(95%CI 85-98%),合并特异度为91%(95%CI 83-96%)。
  • 敏感度存在异质性(I²=50.69%),特异度未见异质性(I²=30.37%)。
  • Meta回归显示回波时间(TE)与研究异质性相关。
  • PRESS序列中长TE(97 ms)的敏感度92%、特异度97%,高于短TE(30-35 ms)的敏感度90%、特异度88%(P<0.01)。
  • 基于个体患者数据得出的2HG最佳截断值为1.76 mM。

关键数值与推荐

  • 2HG最佳截断值为1.76 mM(基于个体患者数据)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 敏感度存在异质性(I²=50.69%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Noninvasive and accurate modality to predict isocitrate dehydrogenase (IDH) mutant glioma may have great potential in routine clinical practice. We aimed to investigate the diagnostic performance of 2-hydroxyglutarate (2HG) magnetic resonance spectroscopy (MRS) for prediction of IDH mutant glioma and provide an optimal cutoff value for 2HG. METHODS: A systematic literature search of Ovid-MEDLINE and EMBASE was performed to identify original articles investigating the diagnostic performance of 2HG MRS up to March 20, 2018. Pooled sensitivity and specificity were calculated using a bivariate random-effects model. Subgroup analysis and meta-regression were performed to explain heterogeneity effects. An optimal cutoff value for 2HG was calculated from studies providing individual patient data. RESULTS: Fourteen original articles with 460 patients were included. The pooled sensitivity and specificity for the diagnostic performance of 2HG MRS for prediction of IDH mutant glioma were 95% (95% CI, 85-98%) and 91% (95% CI, 83-96%), respectively. The Higgins I2 statistic demonstrated that heterogeneity was present in the sensitivity (I2 = 50.69%), but not in the specificity (I2 = 30.37%). In the meta-regression, echo time (TE) was associated with study heterogeneity. Among the studies using point-resolved spectroscopy (PRESS), a long TE (97 ms) resulted in higher sensitivity (92%) and specificity (97%) than a short TE (30-35 ms; sensitivity of 90%, specificity of 88%; P < 0.01). The optimal 2HG cutoff value of 2HG using individual patient data was 1.76 mM. CONCLUSION: 2HG MRS demonstrated excellent specificity for prediction of IDH mutant glioma, with TE being associated with heterogeneity in the sensitivity. KEY POINTS: 1. HG MRS has excellent diagnostic performance in the prediction of IDH mutant glioma. 2. The pooled sensitivity was 95% and the pooled specificity was 91%. 3. Echo time was associated with study heterogeneity in the meta-regression.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Suh CH, Kim HS, Jung SC, et al. 2-Hydroxyglutarate MR spectroscopy for prediction of isocitrate dehydrogenase mutant glioma: a systemic review and meta-analysis using individual patient data. Neuro Oncol. 2018. PMID: 30020513. doi:10.1093/neuonc/noy113

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。